SHOP
+1-4012094076
info@celnovte.com
En
EN CN
SHOP
Home News & Event

PERFECT RESULTS – CELNOVTE 6 primary antibody reagents from Oman partner’s reviews

2022-08-24

By snt_manager

    Share to:

Thank Ms. Kamila Almmawali of Clinical Laboratory, the Sultan Qaboos Comprehensive Cancer Care and Research Center, Muscat, Sultanate of Oman, for her feedback on the test antibody reagents.
Last month, we send to Oman 6 primary antibody reagents: Ki-67, Napsin A, Cdx2, DOG-1, MyoD1, and Myogenin. Recently, we are delighted to see the great affirmation of our products from the “Best Results” reviews.

IHC report for the validation of new antibodies supplied from Henan Celnovte bio

As a leading in vitro diagnostic company in China, we are committed to providing integrated IVD solutions through engineer-qualified products.
Founded in 2010, CELNOVTE Biotech develops and manufactures IVD staining reagents and fully automated systems for oncology pathology, molecular pathology, genetic diseases, prenatal diagnosis, tuberculosis diagnosis, and histology. We offer over 400 primary antibodies, Microstacker detection systems, frozen immunohistochemistry, multiplex stains, specialty stains, tissue HE stains, ISH and automated IHC stainers, and ancillary equipment. We also offer complete diagnostic pathology solutions with a 2000 m2 class 10,000 and 100,000 clean room and a 5000 m2 manufacturing facility.
We look forward to working with more partners worldwide.

Related News